Please login to the form below

Not currently logged in
Email:
Password:

EPEMED appoints executive director

Dr Anne Bruinvels takes leading role at European personalised medicine association, EPEMED

European personalised medicine association, EPEMED, has announced Dr Anne Bruinvels as its new executive director. She is an entrepreneur in personalised healthcare and will be responsible for growing the start-up organisation and building its strategic framework.

The not-for-profit group was established in late 2009 to bring together global forces in personalised medicine. Dr Bruinvels will work with the board to create guidance for all those involved in progressing personalised medicine and European market challenges in particular.

"I'm very pleased with the appointment of Dr Anne Bruinvels as executive director and board member of EPEMED," said Dr Alain Huriez, founder and president of EPEMED.

"Her proven leadership and communication skills in the personalised medicine field will benefit the association greatly and I look forward to working with her to bring harmonisation and education to the personalised medicine field in Europe."

Dr Bruinvels has worked in this arena for over 10 years. She founded personalised healthcare advisory firm, Elixior, and prior to that Curidium, a personalised medicine company identifying companion diagnostics and therapeutics to treat patients with central nervous system disorders. She has also been a researcher for SmithKline Beecham, Wyeth and Sandoz.

She obtained her PhD (neuroscience) from Utrecht University (the Netherlands) and her MSc (pharmacy) from Groningen University (the Netherlands).

3rd June 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Is China ready for a pharmaceutical gold rush?
Some describe doing business in China as akin to the 1990s internet boom – so how stable is its future?...
AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...

Infographics